Key Events This Week
3 Aug: Stock opens week at Rs.302.15 with 1.58% gain
4 Aug: New 52-week high at Rs.308.05; Q1 FY27 results confirm robust growth
5 Aug: Intraday 52-week high surge to Rs.323; closes at Rs.321.90 (+6.61%)
6 Aug: Profit-taking leads to 3.14% decline to Rs.311.80
7 Aug: Recovery with 1.75% gain to close week at Rs.317.25
3 August 2026: Positive Start Amid Broad Market Gains
Artemis Medicare Services Ltd began the week on a positive note, closing at Rs.302.15, up Rs.4.70 or 1.58%. This outpaced the Sensex’s 0.82% gain to 36,985.17 points. The volume of 20,055 shares indicated moderate investor interest. The stock’s early strength set the tone for the week, supported by a broadly favourable market environment and sectoral tailwinds in healthcare.
4 August 2026: New 52-Week High and Strong Quarterly Results
On 4 August, Artemis Medicare hit a new 52-week high of Rs.308.05, closing with a modest 0.30% gain. This milestone reflected sustained momentum, with the stock trading comfortably above all key moving averages. The day’s performance coincided with the release of Q1 FY27 results, which confirmed robust growth and record profitability. Operating profit expanded at an annual rate exceeding 33%, and the company maintained a low Debt to EBITDA ratio of 1.39 times, underscoring financial strength.
The Sensex closed slightly lower at 36,933.47 (-0.14%), highlighting Artemis Medicare’s relative resilience. The company’s Return on Capital Employed (ROCE) remained healthy at 14.21%, while the Debt-Equity ratio was a conservative 0.28 times. These fundamentals supported the stock’s premium valuation, with a Price to Book Value ratio of 5.1 and a Return on Equity (ROE) of 11.3%.
While markets shift, this one's charging ahead! This Micro Cap from Aquaculture shows the strongest momentum signals in current conditions. Don't miss out on this ride!
- - Strongest current momentum
- - Market-cycle outperformer
- - Aquaculture sector strength
5 August 2026: Intraday Surge to Rs.323 and New 52-Week High
The stock’s momentum accelerated sharply on 5 August, surging 6.61% to close at Rs.321.90, with an intraday high of Rs.323. This represented a 7.14% intraday gain from the previous close and significantly outperformed the Sensex’s 0.38% rise to 37,074.66 points. The volume spiked to 113,281 shares, reflecting strong buying interest.
Technical indicators remained bullish, with the stock trading above all major moving averages and supported by positive MACD signals on weekly and monthly charts. The company’s operating profit growth of 33.45% annually and consistent positive quarterly results over ten consecutive quarters reinforced investor confidence. Artemis Medicare’s PEG ratio of 2.5 and a 32.9% profit increase over the past year further validated the stock’s premium valuation.
Despite the strong gains, the stock’s promoter share pledging at 44.53% remains a risk factor that could affect price stability in volatile markets.
6 August 2026: Profit-Taking Leads to Correction
Following the sharp rally, Artemis Medicare experienced profit-taking on 6 August, with the stock declining 3.14% to Rs.311.80 on a volume of 29,063 shares. This pullback was in contrast to the Sensex’s 0.28% gain to 37,177.57 points, indicating selective selling pressure on the stock. The correction was a natural response to the preceding strong gains and did not alter the underlying positive technical and fundamental outlook.
Want to dive deeper on Artemis Medicare Services Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
7 August 2026: Recovery and Weekly Close at Rs.317.25
Artemis Medicare rebounded on the final trading day of the week, gaining 1.75% to close at Rs.317.25 on a volume of 29,640 shares. This recovery outpaced the Sensex’s 0.21% decline to 37,099.57 points, underscoring the stock’s relative strength. The week closed with a net gain of 6.66%, reflecting sustained investor interest and confidence in the company’s growth prospects and financial health.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-03 | Rs.302.15 | +1.58% | 36,985.17 | +0.82% |
| 2026-08-04 | Rs.301.95 | -0.07% | 36,933.47 | -0.14% |
| 2026-08-05 | Rs.321.90 | +6.61% | 37,074.66 | +0.38% |
| 2026-08-06 | Rs.311.80 | -3.14% | 37,177.57 | +0.28% |
| 2026-08-07 | Rs.317.25 | +1.75% | 37,099.57 | -0.21% |
Key Takeaways
Strong Outperformance: Artemis Medicare’s 6.66% weekly gain significantly outpaced the Sensex’s 1.13% rise, highlighting the stock’s robust momentum and investor preference amid a mixed market backdrop.
Technical Strength: The stock consistently traded above all major moving averages throughout the week, supported by bullish MACD and Dow Theory signals on weekly and monthly charts, indicating sustained upward momentum.
Robust Financials: The company’s Q1 FY27 results demonstrated strong operating profit growth (33.45% annualised), low leverage (Debt to EBITDA 1.39x), and solid returns (ROCE 14.21%, ROE 11.3%), underpinning the stock’s premium valuation.
Volatility and Risks: Profit-taking on 6 August caused a notable correction, reflecting short-term volatility. Additionally, the high promoter share pledging at 44.53% remains a cautionary factor that could impact price stability in adverse market conditions.
Conclusion
Artemis Medicare Services Ltd demonstrated a compelling performance during the week of 3 to 7 August 2026, marked by fresh 52-week highs, strong quarterly earnings, and technical resilience. The stock’s 6.66% gain outpaced the broader market, reflecting investor confidence in its operational growth and financial prudence. While short-term volatility and promoter share pledging present risks, the overall trend remains positive as Artemis Medicare consolidates its position within the hospital sector. Investors monitoring this stock should consider both its robust fundamentals and the potential impact of market fluctuations on its near-term price action.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
